Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma

Neuropathology

Volumn 28, Issue 1, 2008, Pages 29-34

  Onguru, Onder ^a   Gamsizkan, Mehmet ^a   Ulutin, Cuneyt ^a   Gunhan, Omer ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Angiogenesis; Cox 2; Cyclooxygenase 2; Glioblastoma; Vascular patterns

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; PROSTAGLANDIN DERIVATIVE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER INVASION; ENZYME MECHANISM; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; UNIVARIATE ANALYSIS;

ADULT; AGED; BRAIN NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 37549012177     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2007.00828.x     Document Type: Article

References (23)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990 82 : 4 6.
2. Sawaoka H, Tsuji S, Tsuji M et al. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 1999 79 : 1469 1478.
3. Tuettenberg J, Grobholz R, Korn T et al. Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme. J Cancer Res Clin Oncol 2005 131 : 31 40.
4. Hansen S, Grabau DA, Rose C et al. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest 1998 78 : 1563 1573.
5. Birner P, Piribauer M, Fischer I et al. Vascular patterns in glioblastoma influence clinical outcome and associate with variable expression of angiogenic proteins: evidence for distinct angiogenic subtypes. Brain Pathol 2003 13 : 133 143.
6. P, Kleihues Cavenee WK. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Nervous System. Lyon : IARC Press, 2000.
7. Preusser M, Birner P, Hainfellner JA. Algorithm for the standardized assessment of vascular patterns in glioblastoma specimens. Clin Neuropathol 2004 23 : 238 240.
8. Hara A, Okayasu I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol (Berl) 2004 108 : 43 48.
9. Shono T, Tofilon PJ, Bruner JM et al. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 2001 61 : 4375 4381.
10. Joki T, Heese O, Nikas DC et al. Expression of cyclooxygenase 2 (Cox-2) in human glioma and in vitro inhibition by a specific Cox-2 inhibitor, NS-398. Cancer Res 2000 60 : 4926 4931.
11. Onguru O, Kurt B, Gunhan O et al. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in intracranial ependymomas. Clin Neuropathol 2006 25 : 216 220.
12. Roma AA, Prayson RA. Expression of cyclo-oxygenase-2 in ependymal tumors. Neuropathology 2006 26 : 422 428.
13. Buccoliero AM, Caldarella A, Arganini L et al. Cyclooxygenase-2 in oligodendroglioma: possible prognostic significance. Neuropathology 2004 24 : 201 207.
14. Castilla EA, Prayson RA, Kanner AA et al. Cyclooxygenase-2 in oligodendroglial neoplasms. Cancer 2003 98 : 1465 1472.
15. Onguru O, Scheithauer BW, Kovacs K et al. Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas. Endocr Pathol 2004 15 : 17 27.
16. Lin CC, Kenyon L, Hyslop T et al. Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade. Am J Clin Oncol 2003 26 : 98 102.
17. Deininger MH, Weller M, Streffer J et al. Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol (Berl) 1999 98 : 240 244.
18. Prayson RA, Castilla EA, Vogelbaum MA et al. Cyclooxygenase-2 (Cox-2) expression by immunohistochemistry in glioblastoma multiforme. Ann Diagn Pathol 2002 6 : 148 153.
19. Sminia P, Stoter TR, van der Valk P et al. Expression of cyclooxygenase-2 and epidermal growth factor receptor in primary and recurrent glioblastoma multiforme. J Cancer Res Clin Oncol 2005 131 : 653 661.
20. Buccoliero AM, Caldarella A, Gheri CF et al. Inducible cyclooxygenase (Cox-2) in glioblastoma - clinical and immunohistochemical (Cox-2-VEGF) correlations. Clin Neuropathol 2006 25 : 59 66.
21. Majima M, Amano H, Hayashi I. Endogenous prostaglandins and angiogenesis. Folia Pharmacol Jpn 2001 117 : 283 292.
22. Sharma S, Sharma MC, Gupta DK et al. Angiogenic patterns and their quantitation in high grade astrocytic tumors. J Neurooncol 2006 79 : 19 30.
23. Preusser M, Heinzl H, Gelpi E et al. Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Cancer 2006 107 : 162 170.